MedTrace Logo

Artesunate Plus Sulfadoxine-pyrimethamine Pharmacokinetics, Efficacy, Gametocytes Carriage and Birth Outcomes in Pregnant Women With Malaria

NCT00331708 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2016-10-26

No results posted yet for this study

Summary

The main purpose of this study is to compare the drug levels of artesunate and sulfadoxine-pyrimethamine found in pregnant women with malaria to those drug levels found in non-pregnant women from other studies. In addition the efficacy and safety of the study drugs will be determined for pregnant women and their babies.

Conditions

Interventions

DRUG

Artesunate plus sulfadoxine-pyrimethamine

Sponsors & Collaborators

  • Global Fund

    collaborator OTHER

  • Medical Research Council, South Africa

    collaborator OTHER

  • Professor Karen I Barnes

    lead OTHER

Principal Investigators

  • Karen I Barnes, MBChB · University of Cape Town

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Primary Completion
2007-07-31
Completion
2007-07-31

Countries

  • Mozambique

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00331708 on ClinicalTrials.gov